Drug · DIN 02562782
NILEMDO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 6, 2026; first marketed February 6, 2026.
- Drug Identification Number (DIN)
- 02562782
- Company (DIN owner)
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bempedoic acid C10AX15
- Class
- Human
- Record last updated
- February 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BEMPEDOIC ACID | 180 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 14, 2025: NOC 36375New Drug Submission (NDS)